Erythrocyte membrane polyunsaturated fatty acid (pufa) levels in a sample of patients with schizophrenia and relation with clinical and progression variables;Niveles de ácidos grasos poliinsaturados (pufa) en la membrana eritrocitaria de una muestra de pacientes con esquizofrenia y su relación con variables clínicas y evolutivas

Actas Espanolas de Psiquiatria

Volumn 43, Issue 5, 2015, Pages 170-176

  Montesinos Rueda, Laura ^a   Cañete Crespillo, Josep ^a   Palma Sevillano, Carolina ^a   Giné Serven, Eloi ^a  

^a HOSPITAL DE MATARÓ   (Spain)

Author keywords

Erythrocyte membranes; Omega 3 polyunsaturated fatty acids; Schizophrenia

Indexed keywords

OMEGA 3 FATTY ACID;

ADULT; BLOOD; CHEMISTRY; CROSS-SECTIONAL STUDY; DISEASE COURSE; ERYTHROCYTE MEMBRANE; FEMALE; HUMAN; MALE; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX;

ADULT; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; ERYTHROCYTE MEMBRANE; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; MALE; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX;

EID: 84941349568     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Horrobin DF, Bennet CN. Phospholipids metabolism and the patophisiology of psychiatric and neurological disorders in Phospholipids spectrum disorders psychiatry and neurology. Peet M, Glenn I, Horrobin Df, eds. Marius Press. Carnfordh; 2003. p. 3-47.
2. Du Bois TM, Deng CH, Huang XF. Membrane phospholipid composition, alterations in neurotransmitter systems and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29:878-88.
3. Das UN. Essential fatty acids-a review. Curr Pharm Biotechnol. 2006;7:467-82.
4. Das UN. Biological signifcance of essential fatty acids. JAPI. 2006;54:309-19.
5. Horrobin DF, Glen AI, Vaddadi K. The membrane hypothesis of schizophrenia. Schizophr Res. 1994;13 (3):195-207.
6. Christensen O, Christensen F. fat consumption and schizophrenia. Act Psychiat Scand. 1988;78:587-91.
7. Fekete K, Marosvolgyi T, Jakobik V, Decsi T. Methods of assesment of n-e long-chain polyunsaturated fatty acid status in humans: a systematic review. Am J Clin Nutr. 2009;89(suppl):2070S-84S.
8. Yao JK. Abnormalities of fatty acid metabolism in red cells, platelets and brain in schizophrenia in Phospholipids spectrum disorders psychiatry and neurology. Peet M, Glenn I, Horrobin Df, eds. Marius Press. Carnfordh; 2003. p. 193-212.
9. Assies J, Lieverse R, Vreken P, Wanders RJA, Dingemans PMJA, Linnszen DH. Signifcally reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group. Biol Psychiatry. 2001;49:510-22.
10. Nuss P, Tessier C, ferrari f, De Hert M, Peuskens J, Trugnan G, et al. Abnormal transbilayer distribution of phospholipids in red blood cell membranes in schizophrenia. Psychiatry Res. 2009;169:91-6.
11. Khan MM, Evans DR, Gunna V, Scheffer RE, Parikh VV, Mahadik SP. Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated frst-episode of psychosis and after years of treatment with antipsychotics. Schizophr Res. 2002;58(1):1-10.
12. Sumiyoshi T, Higuchi Y, Matsui M, Itoh H, uehara T, Itoh T, et al. Membrane fatty acid levels as a predictor of treatment response in chronic schizophrenia. Psychiatry Research 2011;186:23-7.
13. Van der Kemp WJ, Klomp DW, Kahn RS, Luijten PR, Hulshoff HE. A meta-analysis of the polyunsaturated fatty acid composition of erythrocyte membranes in schizophrenia. Schizophr Res. 2012;141(2-3):153-61.
14. McNamara RK. Omega-3 fatty acid defciency: a preventable risk factor for schizophrenia? Schizophr Res. 2011;129(2-3):215-6.
15. Bentsen H, Solberg DK, Refsum H, Bøhmer T. Clinical and biochemical validation of two endophenotypes of schizophrenia defned by levels of polyunsaturated fatty acids in red blood cells. Prostaglandins Leukot Essent fatty Acids. 2012;87:35-41.
16. Sumiyoshi T, Matsui M, Itoh H, Higuchi Y, Arai H, Takamiya C, et al. Essential polyunsaturated fatty acids and social cognition in schizophrenia. Psychiatry Research. 2008;1157:87-93.
17. American Psychiatric Association. DSM-IV-TR: Diagnostic and Statistical manual of mental Disorders. 4 ed. Washington: American Psychiatric Association; 2000.
18. Lepage G, Roy C. Direct transesterifcation of all classes of lipids in a one-step reaction. J Lipid Res. 1986;27:114-20.
19. Kay SR, fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261-76.
20. Guy W. ECDEu Assesment Manual of Psychofarmacology. Rockville, MD: uS Department of Health, Education and Welfare Public Health Service Alcohol, Drug Abuse and Mental Health Administration; 1976.
21. Pino O, Guilera G, Gómez J, Rojo E, Vallejo J, Purdon S. Escala breve para evaluar el deterioro cognitivo en pacientes psiquiátricos. Psicothema. 2006;18(3):447-52.
22. Garcia-Portilla MP, Saiz PA, Bousoño M. Validación de la versión española de la Escala de funcionamiento Personal y Social en pacientes ambulatorios con esquizofrenia estable o inestable. Rev Psiquiatr Salud Ment. 2011;4(1):9-18.
23. Fernández-Ballart JD, Piñol JL, Zazpe I, Corella D, Carrasco P, Toledo E, et al. Relative validity of a semi-quantitative food-frequency questionnaire in an elderly Mediterranean population of Spain. Br J Nutr. 2010;103:1808-16.
24. Sethom MM, fares S, Bouaziz N, Melki W, Jemaa R, feki M, et al. Polyunsaturated fatty acids defcits are associatred with psicotic state and negative symptoms in patients with schizophrenia. Prostaglandins Leukot Essent fatty Acids. 2010;83:131-6.
25. Block RC, Harris WS, Pottala JV. Clinical investigation: determinants of blood cell omega-3 fatty acid content. Open Biomark J. 2008;1:1-6.
26. Giltay EJ, Gooren L, Toorians A, Katan MB, Zock PL. Docosahexaenoic acid concentrations are higher in women than in men because of estrogenic effects. Am J Clin Nutr. 2004;80:1167-74.
27. Ochoa S, usall J, Cobo J, Labad X, Kulkarni J. Gender Differences in Schizophrenia and first-Episode Psychosis: A Comprehensive Literature Review. Schizophr Res Treatment. 2012;2012:916198.
28. Das UN. Essential fatty acids and their metabolites could function as endogeneous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrythmic, anti-hypertensive, anti-atherosclerotic, anti-infamatory, cytoprotective and cardioprotective molecules. Lipids Health Dis. 2008;7:37-55.
29. Simopoulos AP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med. 2008;233:674-88.